PRSS22 and neoplasm: In a GC mouse model, PRSS22 downregulation decreased tumor volume and weight, elevated the activity levels of caspase-3/7/9, reduced the mRNA expressions of Cox2, TNF-α, and Myc, and increased the TP53 mRNA expression in tumor tissues (Fig. 2).